Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04553692
Title Study of IGM-8444 as a Single Agent and in Combination With Chemotherapy-based Regimens in Subjects With Solid Cancers
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors IGM Biosciences, Inc.
Indications

Advanced Solid Tumor

Therapies

Bevacizumab + Fluorouracil + IGM-8444 + Irinotecan + Leucovorin

Fluorouracil + IGM-8444 + Irinotecan + Leucovorin

IGM-8444

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.